Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03221244 · ClinicalTrials.gov registry record · NA

Virtual Reality Attention Management

A NA study of ADHD, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03221244: Recruiting NA study of ADHD, sponsored by University of California, Davis.

NCT03221244 is a NA study of ADHD that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03221244, a NA study of ADHD, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Problems with distraction are widespread in the 21st century, but for people with developmental delays or behavioral challenges they can have more damaging effects. For example, susceptibility to distraction is associated with worse school and social performance, lower high school graduation rates, and increased incidence of serious accidents. The investigators' goal is to improve understanding of distractibility and develop a targeted treatment. The proposed intervention is based on models of habituation, which is a term that means reduced physiological and emotional response to a stimulus (e.g. moving object, or loud noise, etc.) as it is seen repeatedly. The investigators use virtual reality technology to show study participants distracting stimuli repeatedly in a virtual classroom setting, and their hypothesis states that participants will improve attention in the face of distraction by training with this technology intervention. The virtual classroom setting is especially relevant for children who have significant challenges with distractibility, such as children with ADHD. This intervention will likely be effective in helping individuals with other clinical disorders and perhaps the general population as well.

Primary Outcome

Successful distractor suppression = improvement in number of orienting eye saccades toward distractors and duration of fixations by a statistical effect size of 0.5 or greater.

Conditions Studied

Interventions

  • DEVICE VR Treatment
  • DEVICE VR Active Control

Study Locations (1)

California

  • UC Davis MIND Institute - Sacramento

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-06-02
Est. Completion 2027-07-02
Phase NA
University of California, Davis

657 total trials

What NCT03221244 shows while recruiting

NCT03221244 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (74% lower).

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which VR Treatment is the first listed.

NCT03221244 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03221244 about?

NCT03221244 is a clinical study titled "Virtual Reality Attention Management". Problems with distraction are widespread in the 21st century, but for people with developmental delays or behavioral challenges they can have more damaging effects. For example, susceptibility to distraction is associated with worse school and social performance, lower high school graduation rates, ...

What is the current status of trial NCT03221244?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2016-06-02. Estimated completion is 2027-07-02.

What conditions does trial NCT03221244 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT03221244?

The interventions under investigation include: VR Treatment (DEVICE), VR Active Control (DEVICE).

Who is sponsoring clinical trial NCT03221244?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03221244 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03221244's enrollment target sits among peer trials

50 45th of 75 higher than 28 of 75 other ADHD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03221244, the US trial registry maintained by the National Library of Medicine. NCT03221244 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.